Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kitchener

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Lancet (London, England)|July 10, 2009
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenJ Paavonen, P Naud, J Salmerón, et al.
International Journal of Cancer|August 23, 2011
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18A Szarewski, W A J Poppe, S R Skinner, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2014
Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samplesL Alemany, M Saunier, L Tinoco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2005
3rd International Ovarian Cancer Consensus Conference: outstanding issues for future considerationG Stuart, E Avall-Lundqvist, A du Bois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2005
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)A du Bois, M Quinn, T Thigpen, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Lancet (London, England)|July 10, 2009
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenJ Paavonen, P Naud, J Salmerón, et al.
International Journal of Cancer|August 23, 2011
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18A Szarewski, W A J Poppe, S R Skinner, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2014
Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samplesL Alemany, M Saunier, L Tinoco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2005
3rd International Ovarian Cancer Consensus Conference: outstanding issues for future considerationG Stuart, E Avall-Lundqvist, A du Bois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2005
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)A du Bois, M Quinn, T Thigpen, et al.
Pageof 6